Sort   by:  
 Page size 
UnknownHotspots and trends in multiple myeloma bone diseases: A bibliometric visualization analysis.
Not available
S-EPMC9614215 | biostudies-literature
UnknownBone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma.
Not available
S-EPMC4606491 | biostudies-literature
UnknownClinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.
Not available
S-EPMC7156404 | biostudies-literature
UnknownBCMA in Multiple Myeloma-A Promising Key to Therapy.
Not available
S-EPMC8472544 | biostudies-literature
UnknownThe Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma.
Not available
S-EPMC10742268 | biostudies-literature
UnknownThe Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma.
Not available
S-EPMC9778728 | biostudies-literature
UnknownPomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma.
Not available
S-EPMC9109494 | biostudies-literature
UnknownClinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection.
Not available
S-EPMC7335864 | biostudies-literature
UnknownLate-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.
Not available
S-EPMC8646944 | biostudies-literature
UnknownHow I treat elderly patients with plasma cell dyscrasias.
Not available
S-EPMC6326666 | biostudies-literature
Sort   by:  
 Page size